Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new treatments and diagnostics easier and quicker, new research has found. In a paper ...
Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new treatments and diagnostics easier and quicker, new research has found. In a paper ...
Researchers working on an incurable blood cancer can now use a new lab model, which could make testing potential new treatments and diagnostics easier and quicker, new research has found. In a paper ...
Pretreatment testing for CEBPA mutations identifies CN-AML patients with different outcomes, particularly in the molecular high-risk group, thus improving molecular risk-based classification of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results